Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

A metagenome-wide association study of gut microbiota in type 2 diabetes.

Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D, Peng Y, Zhang D, Jie Z, Wu W, Qin Y, Xue W, Li J, Han L, Lu D, Wu P, Dai Y, Sun X, Li Z, Tang A, Zhong S, Li X, Chen W, Xu R, Wang M, Feng Q, Gong M, Yu J, Zhang Y, Zhang M, Hansen T, Sanchez G, Raes J, Falony G, Okuda S, Almeida M, LeChatelier E, Renault P, Pons N, Batto JM, Zhang Z, Chen H, Yang R, Zheng W, Li S, Yang H, Wang J, Ehrlich SD, Nielsen R, Pedersen O, Kristiansen K, Wang J.

Nature. 2012 Oct 4;490(7418):55-60. doi: 10.1038/nature11450. Epub 2012 Sep 26.

PMID:
23023125
2.

Microbiota and diabetes: an evolving relationship.

Tilg H, Moschen AR.

Gut. 2014 Sep;63(9):1513-21. doi: 10.1136/gutjnl-2014-306928. Epub 2014 May 15. Review.

PMID:
24833634
3.

Metagenomics: key to human gut microbiota.

Maccaferri S, Biagi E, Brigidi P.

Dig Dis. 2011;29(6):525-30. doi: 10.1159/000332966. Epub 2011 Dec 12. Review.

PMID:
22179207
4.

A metagenomic insight into our gut's microbiome.

Lepage P, Leclerc MC, Joossens M, Mondot S, Blottière HM, Raes J, Ehrlich D, Doré J.

Gut. 2013 Jan;62(1):146-58. doi: 10.1136/gutjnl-2011-301805. Epub 2012 Apr 23. Review.

PMID:
22525886
5.

Application of metagenomics in the human gut microbiome.

Wang WL, Xu SY, Ren ZG, Tao L, Jiang JW, Zheng SS.

World J Gastroenterol. 2015 Jan 21;21(3):803-14. doi: 10.3748/wjg.v21.i3.803. Review.

6.

Intestinal MicrobiOMICS to define health and disease in human and mice.

Serino M, Chabo C, Burcelin R.

Curr Pharm Biotechnol. 2012 Apr;13(5):746-58. Review.

PMID:
22122483
7.

The human gut microbiome and body metabolism: implications for obesity and diabetes.

Devaraj S, Hemarajata P, Versalovic J.

Clin Chem. 2013 Apr;59(4):617-28. doi: 10.1373/clinchem.2012.187617. Epub 2013 Feb 11. Review.

8.

Techniques used to characterize the gut microbiota: a guide for the clinician.

Fraher MH, O'Toole PW, Quigley EM.

Nat Rev Gastroenterol Hepatol. 2012 Mar 27;9(6):312-22. doi: 10.1038/nrgastro.2012.44. Review.

PMID:
22450307
9.

The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus.

Kootte RS, Vrieze A, Holleman F, Dallinga-Thie GM, Zoetendal EG, de Vos WM, Groen AK, Hoekstra JB, Stroes ES, Nieuwdorp M.

Diabetes Obes Metab. 2012 Feb;14(2):112-20. doi: 10.1111/j.1463-1326.2011.01483.x. Epub 2011 Nov 22. Review.

PMID:
21812894
10.

Single cell genome sequencing.

Yilmaz S, Singh AK.

Curr Opin Biotechnol. 2012 Jun;23(3):437-43. doi: 10.1016/j.copbio.2011.11.018. Epub 2011 Dec 7. Review.

11.

Is the origin of type 1 diabetes in the gut?

Vaarala O.

Immunol Cell Biol. 2012 Mar;90(3):271-6. doi: 10.1038/icb.2011.115. Epub 2012 Jan 31. Review.

PMID:
22290506
12.

Recent advances in molecular approaches to gut microbiota in inflammatory bowel disease.

Andoh A, Benno Y, Kanauchi O, Fujiyama Y.

Curr Pharm Des. 2009;15(18):2066-73. Review.

PMID:
19519444
13.

[Intestinal microbiota and novel therapeutic perspectives for the treatment of metabolic diseases].

Burcelin R, Chabo C, Blasco-Baque V, Sérino M, Amar J.

Med Sci (Paris). 2013 Aug-Sep;29(8-9):800-6. doi: 10.1051/medsci/2013298021. Epub 2013 Sep 5. Review. French.

14.

From bacterial to microbial ecosystems (metagenomics).

Williamson SJ, Yooseph S.

Methods Mol Biol. 2012;804:35-55. doi: 10.1007/978-1-61779-361-5_3. Review.

PMID:
22144147
15.

Metagenomics and probiotics.

Gueimonde M, Collado MC.

Clin Microbiol Infect. 2012 Jul;18 Suppl 4:32-4. doi: 10.1111/j.1469-0691.2012.03873.x. Review.

16.

From basic to applied research: lessons from the human microbiome projects.

Robles-Alonso V, Guarner F.

J Clin Gastroenterol. 2014 Nov-Dec;48 Suppl 1:S3-4. doi: 10.1097/MCG.0000000000000242. Review.

PMID:
25291122
17.

The impact of antibiotics on the gut microbiota as revealed by high throughput DNA sequencing.

Cotter PD, Stanton C, Ross RP, Hill C.

Discov Med. 2012 Mar;13(70):193-9. Review.

18.

Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding.

Cani PD, Delzenne NM, Amar J, Burcelin R.

Pathol Biol (Paris). 2008 Jul;56(5):305-9. doi: 10.1016/j.patbio.2007.09.008. Epub 2008 Jan 30. Review.

PMID:
18178333
19.

Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?

Esteve E, Ricart W, Fernández-Real JM.

Curr Opin Clin Nutr Metab Care. 2011 Sep;14(5):483-90. doi: 10.1097/MCO.0b013e328348c06d. Review.

PMID:
21681087
20.

Targeted metagenomics: a high-resolution metagenomics approach for specific gene clusters in complex microbial communities.

Suenaga H.

Environ Microbiol. 2012 Jan;14(1):13-22. doi: 10.1111/j.1462-2920.2011.02438.x. Epub 2011 Mar 1. Review.

PMID:
21366818
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk